XML 14 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2021 $ 167,203 $ 3 $ 242,939 $ (123) $ (75,616)
Beginning balance, shares at Dec. 31, 2021   26,235,317      
Vesting Of Restricted Stock Awards Shares   9,451      
Stock-based compensation 1,541   1,541    
Other comprehensive loss (398)     (398)  
Net loss (13,204)       (13,204)
Ending balance at Mar. 31, 2022 155,142 $ 3 244,480 (521) (88,820)
Ending balance, shares at Mar. 31, 2022   26,244,768      
Beginning balance at Dec. 31, 2021 167,203 $ 3 242,939 (123) (75,616)
Beginning balance, shares at Dec. 31, 2021   26,235,317      
Net loss (37,482)        
Ending balance at Sep. 30, 2022 134,359 $ 3 248,035 (581) (113,098)
Ending balance, shares at Sep. 30, 2022   26,348,371      
Beginning balance at Mar. 31, 2022 155,142 $ 3 244,480 (521) (88,820)
Beginning balance, shares at Mar. 31, 2022   26,244,768      
Vesting Of Restricted Stock Awards Shares   82,633      
Stock-based compensation 1,772   1,772    
Other comprehensive loss (83)     (83)  
Net loss (14,596)       (14,596)
Ending balance at Jun. 30, 2022 142,235 $ 3 246,252 (604) (103,416)
Ending balance, shares at Jun. 30, 2022   26,327,401      
Vesting Of Restricted Stock Awards Shares   20,970      
Stock-based compensation 1,783   1,783    
Other comprehensive loss 23     23  
Net loss (9,682)       (9,682)
Ending balance at Sep. 30, 2022 134,359 $ 3 248,035 (581) (113,098)
Ending balance, shares at Sep. 30, 2022   26,348,371      
Beginning balance at Dec. 31, 2022 128,715 $ 3 249,930 (358) (120,860)
Beginning balance, shares at Dec. 31, 2022   26,390,186      
Vesting Of Restricted Stock Awards Shares   19,608      
Exercise of stock options 1   1    
Exercise of stock options , shares   406,194      
Stock-based compensation 10,171   10,171    
Other comprehensive loss 263     263  
Net loss (22,290)       (22,290)
Ending balance at Mar. 31, 2023 116,860 $ 3 260,102 (95) (143,150)
Ending balance, shares at Mar. 31, 2023   26,815,988      
Beginning balance at Dec. 31, 2022 $ 128,715 $ 3 249,930 (358) (120,860)
Beginning balance, shares at Dec. 31, 2022   26,390,186      
Exercise of stock options , shares 889,404        
Net loss $ (31,478)        
Ending balance at Sep. 30, 2023 109,742 $ 3 262,088 (11) (152,338)
Ending balance, shares at Sep. 30, 2023   27,370,508      
Beginning balance at Mar. 31, 2023 116,860 $ 3 260,102 (95) (143,150)
Beginning balance, shares at Mar. 31, 2023   26,815,988      
Vesting Of Restricted Stock Awards Shares   44,038      
Exercise of stock options 24   24    
Exercise of stock options , shares   23,526      
Stock-based compensation 777   777    
Other comprehensive loss 60     60  
Net loss (5,220)       (5,220)
Ending balance at Jun. 30, 2023 112,501 $ 3 260,903 (35) (148,370)
Ending balance, shares at Jun. 30, 2023   26,883,552      
Vesting Of Restricted Stock Awards Shares   27,272      
Exercise of stock options 529   529    
Exercise of stock options , shares   459,684      
Stock-based compensation 656   656    
Other comprehensive loss 24        
Net loss (3,968)       (3,968)
Ending balance at Sep. 30, 2023 $ 109,742 $ 3 $ 262,088 $ (11) $ (152,338)
Ending balance, shares at Sep. 30, 2023   27,370,508